Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β

Pellikainen, 2007, Activator protein-2 in carcinogenesis with a special reference to breast cancer—a mini review, Int J Cancer, 120, 2061, 10.1002/ijc.22648 Moser, 1997, Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis, Dev Dyn, 208, 115, 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5 Seki, 2015, AP-2beta is a transcriptional regulator for determination of digit length in tetrapods, Dev Biol, 407, 75, 10.1016/j.ydbio.2015.08.006 Martino, 2016, Conditional deletion of AP-2beta in mouse cranial neural crest results in anterior segment dysgenesis and early-onset glaucoma, Dis Model Mech, 9, 849 Hesse, 2011, AP-2delta is a crucial transcriptional regulator of the posterior midbrain, PLoS One, 6, e23483, 10.1371/journal.pone.0023483 Satoda, 2000, Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus, Nat Genet, 25, 42, 10.1038/75578 Lindgren, 2009, Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution, PLoS Genet, 5, e1000508, 10.1371/journal.pgen.1000508 Wachtel, 2006, Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry, J Clin Oncol, 24, 816, 10.1200/JCO.2005.03.4934 Ebauer, 2007, Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR, Oncogene, 26, 7267, 10.1038/sj.onc.1210525 Ikram, 2016, Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma, Mol Oncol, 10, 344, 10.1016/j.molonc.2015.10.020 Li, 2010, AP2 transcription factor induces apoptosis in retinoblastoma cells, Genes Chromosomes Cancer, 49, 819 Grass, 2009, Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics, Histopathology, 54, 873, 10.1111/j.1365-2559.2009.03303.x Turner, 1998, Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways, Cancer Res, 58, 5466 Pellikainen, 2002, Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer, Clin Cancer Res, 8, 3487 Orso, 2004, Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region, Biochem J, 377, 429, 10.1042/bj20031133 Friedrichs, 2005, Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer, Mod Pathol, 18, 431, 10.1038/modpathol.3800292 Gee, 2009, Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival, J Pathol, 217, 32, 10.1002/path.2430 Williams, 2009, AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene, EMBO J, 28, 3591, 10.1038/emboj.2009.290 Shiu, 2013, Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies, Oncogene, 33, 619, 10.1038/onc.2012.625 Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Hu, 2006, The molecular portraits of breast tumors are conserved across microarray platforms, BMC Genomics, 7, 96, 10.1186/1471-2164-7-96 Weigelt, 2010, The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type, J Pathol, 220, 45, 10.1002/path.2629 Guedj, 2012, A refined molecular taxonomy of breast cancer, Oncogene, 31, 1196, 10.1038/onc.2011.301 Korkola, 2003, Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis, Cancer Res, 63, 7167 Otto, 2013, Transcription factors link mouse WAP-T mammary tumors with human breast cancer, Int J Cancer, 132, 1311, 10.1002/ijc.27941 Christgen, 2013, IPH-926 lobular breast cancer cells are triple-negative but their microarray profile uncovers a luminal subtype, Cancer Sci, 104, 1726, 10.1111/cas.12276 Christgen, 2008, KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer, Int J Cancer, 123, 2239, 10.1002/ijc.23806 Gluz, 2016, West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and concordance of prognostic markers by central and local pathology assessment, J Clin Oncol, 34, 2341, 10.1200/JCO.2015.63.5383 Schulze-Garg, 2000, A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland, Oncogene, 19, 1028, 10.1038/sj.onc.1203281 Meyer, 2011, Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors, Cancer Res, 71, 4344, 10.1158/0008-5472.CAN-10-3827 Derksen, 2011, Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice, Dis Model Mech, 4, 347, 10.1242/dmm.006395 Boelens, 2016, PTEN loss in E-Cadherin-deficient mouse mammary epithelial cells rescues apoptosis and results in development of classical invasive lobular carcinoma, Cell Rep, 16, 2087, 10.1016/j.celrep.2016.07.059 Mengel, 2002, Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial, J Pathol, 198, 292, 10.1002/path.1218 Remmele, 1987, [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue], Pathologe, 8, 138 Christgen, 2009, Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer, J Pathol, 217, 620, 10.1002/path.2495 Christgen, 2010, Down-regulation of the fetal stem cell factor SOX17 by H33342: a mechanism responsible for differential gene expression in breast cancer side population cells, J Biol Chem, 285, 6412, 10.1074/jbc.M109.082941 Krech, 2012, ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells, Cancer Lett, 315, 153, 10.1016/j.canlet.2011.09.038 Christgen, 2015, Lobular breast cancer: molecular basis, mouse and cellular models, Breast Cancer Res, 17, 16, 10.1186/s13058-015-0517-z Dirks, 2005, Short tandem repeat DNA typing provides an international reference standard for authentication of human cell lines, Altex, 22, 103 Christgen, 2012, IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes, Lab Invest, 92, 1635, 10.1038/labinvest.2012.126 Uphoff, 2005, Detection of mycoplasma contaminations, Methods Mol Biol, 290, 13 Fuchs, 2004, Dynamics of cell adhesion and motility in living cells is altered by a single amino acid change in E-cadherin fused to enhanced green fluorescent protein, Cell Motil Cytoskelet, 59, 50, 10.1002/cm.20019 Karch, 2013, Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?, PLoS One, 8, e73062, 10.1371/journal.pone.0073062 Christgen, 2007, Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line, Mol Cell Biochem, 306, 201, 10.1007/s11010-007-9570-y Christgen, 2016, Lobular breast cancer: clinical, molecular and morphological characteristics, Pathol Res Pract, 212, 583, 10.1016/j.prp.2016.05.002 Christgen, 2017, Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid-papillary carcinoma, J Pathol Clin Res, 3, 191, 10.1002/cjp2.76 Gluz, 2016, The WSG Phase III PlanB Trial: first prospective outcome data for the 21-gene recurrence score assay and concordance of prognostic markers by central and local pathology assessment, J Clin Oncol, 34, 2341, 10.1200/JCO.2015.63.5383 Frasor, 2004, Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells, Cancer Res, 64, 1522, 10.1158/0008-5472.CAN-03-3326 Lee, 2007, Alterations of gene expression in the development of early hyperplastic precursors of breast cancer, Am J Pathol, 171, 252, 10.2353/ajpath.2007.061010 Robinson, 2011, Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1, EMBO J, 30, 3019, 10.1038/emboj.2011.216